2019
DOI: 10.1111/sjop.12549
|View full text |Cite
|
Sign up to set email alerts
|

Social and non‐social measures of cognition for predicting self‐reported and informant‐reported functional outcomes in early psychosis

Abstract: The main aim of this study was to investigate the individual contributions of neurocognitive and social‐cognitive domains to self‐reported and informant‐reported functional outcome in early psychosis. We also sought to further characterize the nature of cognitive impairments in this sample and explore the interrelationships between the social‐cognitive measures and how they correlate with measures of neurocognition and clinical symptoms. In this study, 70 patients (mean age: 24.1; 87.1% males) with primary psy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 62 publications
0
1
0
Order By: Relevance
“…Moreover, the BDI-II includes items concerning anhedonia, asociality and avolition, which overlap with the experiential domain of negative symptoms that we evaluated with the Brief Negative Symptoms Scale (BNSS) 38 . Similarly, according to the current conceptualization of negative symptoms 39 , we assessed negative symptoms with a specific second-generation assessment scales, the BNSS, considering two factors: avolition and expressive deficits 40,41 , whereas previous studies did not employ specific scales and considered negative symptoms as a single variable 7,32,37,[42][43][44] . These differences in clinical assessment could at least in part account for our contrasting results compared with previous works.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the BDI-II includes items concerning anhedonia, asociality and avolition, which overlap with the experiential domain of negative symptoms that we evaluated with the Brief Negative Symptoms Scale (BNSS) 38 . Similarly, according to the current conceptualization of negative symptoms 39 , we assessed negative symptoms with a specific second-generation assessment scales, the BNSS, considering two factors: avolition and expressive deficits 40,41 , whereas previous studies did not employ specific scales and considered negative symptoms as a single variable 7,32,37,[42][43][44] . These differences in clinical assessment could at least in part account for our contrasting results compared with previous works.…”
Section: Discussionmentioning
confidence: 99%